Newsroom

LONDON--(BUSINESS WIRE)--  POST-STABILISATION ANNOUNCEMENT Date: 16th July, 2026 Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful. Schneider Electric SE Post-stabilisation Period Announcement Further to the pre-stabilisation period announcement dated 25th June 2026, Natixis (Christopher Agathangelou - Syndicate Contact; telephone: +33158550814) hereby gives notice that no stabilisation (within the meaning...

LONDON--(BUSINESS WIRE)--  POST-STABILISATION ANNOUNCEMENT Date: 16th July 2026 Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful. Compagnie de financement foncier Post-stabilisation Period Announcement Further to the pre-stabilisation period announcement dated 29th June 2026, Natixis (contact: Christopher Agathangelou; telephone: 0158550814) hereby gives notice that no stabilisation (within the meaning of...

LONDON--(BUSINESS WIRE)--  POST-STABILISATION ANNOUNCEMENT Date: 16th July 2026 Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful. Compagnie de financement foncier Post-stabilisation Period Announcement Further to the pre-stabilisation period announcement dated 29th June 2026, Natixis (contact: Christopher Agathangelou; telephone: 0158550814) hereby gives notice that no stabilisation (within the meaning of...

LONDON--(BUSINESS WIRE)--  POST-STABILISATION ANNOUNCEMENT Date: 16th July, 2026 Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful. CADES Post-stabilisation Period Announcement Further to the pre-stabilisation period announcement dated 23rd June 2026, Natixis (Christopher Agathangelou - Syndicate Contact; telephone: +33158550814) hereby gives notice that no stabilisation (within the meaning of Article 3.2(...

LONDON--(BUSINESS WIRE)--  POST-STABILISATION ANNOUNCEMENT Date: 16th July, 2026 Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful. Caisse de Refinancement de l’Habitat - CRH Post-stabilisation Period Announcement Further to the pre-stabilisation period announcement dated 18th June 2026, Natixis (Christopher Agathangelou - Syndicate Contact; telephone: +33158550814) hereby gives notice that no stabilisatio...

DALLAS--(BUSINESS WIRE)--Jacobs is selected as one of several service providers under a multidisciplinary framework agreement with TransnetBW in Germany....

LONDON--(BUSINESS WIRE)--  POST-STABILISATION ANNOUNCEMENT Date: 16th July 2026 Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful. BPCE SA Post-stabilisation Period Announcement Further to the pre-stabilisation period announcement dated 16 June 2026, Natixis (contact: Christopher Agathangelou; telephone: 0158550814) hereby gives notice that no stabilisation (within the meaning of Article 3.2(d) of the Mark...

LONDON--(BUSINESS WIRE)--  POST-STABILISATION ANNOUNCEMENT Date: 16th July 2026 Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful. ACTION LOGEMENT SERVICES Post-stabilisation Period Announcement Further to the pre-stabilisation period announcement dated 9th July 2026, Natixis (contact: Christopher Agathangelou; telephone: 0158550814) hereby gives notice that no stabilisation (within the meaning of Article...

VILLEJUIF, France--(BUSINESS WIRE)--Regulatory News: Valerio Therapeutics (FR0010095596 – ALVIO), société de biotechnologie pionnière développant une nouvelle génération de thérapies de précision fondées sur l'ARN (« Valerio » ou la « Société »), annonce aujourd'hui avoir conclu une term-sheet engageante avec Abivax SA (« Abivax »), définissant les principaux termes d'une collaboration mondiale exclusive en matière de recherche et développement. Les modalités définitives demeurent soumises à la...

VILLEJUIF, France--(BUSINESS WIRE)--Regulatory News: Valerio Therapeutics (FR0010095596 – ALVIO), a biotechnology company pioneering next-generation precision-guided RNA therapeutics (“Valerio” or the “Company”), today announces that it has entered into a binding term-sheet with Abivax SA (“Abivax”), setting out the principal terms of an exclusive worldwide research and development collaboration. The final terms remain subject to the signing of the definitive co-ownership and license agreement....